Dr. Paul F. Kent, MD

Dr. Kent practices at Columbia University Irving Medical Center in New York, New York.

Dr. Kent's NPI, 1043268154, was assigned on May 4, 2006. Dr. Kent graduated from SUNY Upstate Medical University in 1989. Dr. Kent holds New York license 197590.

Dr. Kent's primary practice is Columbia University Irving Medical Center, at 622 W 168th St, New York, NY 10032 in New York County. The practice phone is (212) 297-4255.

Dr. Kent's primary practice is Columbia University Irving Medical Center in New York, New York. Dr. Kent is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Kent to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kent practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Kent's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Kent is board certified in clinical neurophysiology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Kent's licenses on file in 2 states: New York and Florida.

Dmand AI lists epilepsy and seizures among the conditions Dr. Kent treats.

CMS data shows 2,511 Medicare services from Dr. Kent across 8 procedure codes in 2024, for 279 Medicare patients. Medicare paid $107,381 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 279 Medicare patients who saw Dr. Kent in 2024. The largest group is 65 to 74, with 116 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 27% are also on Medicaid. Their average risk score is 1.92, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kent's median patient age at 55, with 51% women.

In 2024, Dr. Kent wrote 85 Medicare Part D claims for 30 patients. 92% of them were for generic drugs. CMS names the drug for 36 of them, across 2 drugs with 11 or more claims each, at $4,558 in total drug cost. In 2023, CMS named 42 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Kent for performance year 2024, reported through an alternative payment model (APM). Dr. Kent accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kent as offering telehealth.

Dmand AI links 31 papers to Dr. Kent, published from 2003 to 2025. 2012 was the busiest year, with 2. The most frequent topics are Odorants, Olfactory Mucosa and Smell. Dr. Kent has published most often in Brain Res. Dr. Kent's most frequent co-authors are Cigdem Inan Akman, MD, Deepti Anbarasan, MD and Lisa M. Bateman, MD.

CMS Open Payments shows 6 general payments to Dr. Kent from 4 drug and device companies from 2016 to 2022. Food and beverage make up the largest share, 100% of the total. Monteris Medical Corporation paid the most, $238.

Dr. Kent graduated from SUNY Upstate Medical University in 1989.

Dr. Kent is in network with 15 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.